Akshaj Molecular Research Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -84.26%
- Ebitda 12412.03%
- Net Worth -39.72%
- Total Assets -35.69%
About Akshaj Molecular Research
Akshaj Molecular Research Private Limited (AMRPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 December 2013 and has a history of 11 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Lenin Babu, Srinivasulu Nampally, Janardhan Nampalli, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2013PTC092035
-
Company No.
092035
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Dec 2013
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Akshaj Molecular Research?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lenin Babu
|
Director | 31-Dec-2013 | Current |
|
Srinivasulu Nampally
|
Director | 31-Dec-2013 | Current |
|
Janardhan Nampalli
|
Director | 26-Jul-2014 | Current |
|
Kiran Cherupally
|
Director | 29-Sep-2015 | Current |
Financial Performance of Akshaj Molecular Research.
Akshaj Molecular Research Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 84.26% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akshaj Molecular Research?
Unlock access to Akshaj Molecular Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Akshaj Molecular Research?
Unlock and access historical data on people associated with Akshaj Molecular Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshaj Molecular Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshaj Molecular Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
